These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4913800

  • 1. Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid.
    Henman FD.
    Gut; 1970 Apr; 11(4):344-51. PubMed ID: 4913800
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of peptic activity in man by carbenoxolyne sodium.
    Berstad A.
    Scand J Gastroenterol; 1972 Apr; 7(2):129-35. PubMed ID: 4553652
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Carbenoxolone sodium.
    Sircus W.
    Gut; 1972 Oct; 13(10):816-24. PubMed ID: 4564085
    [No Abstract] [Full Text] [Related]

  • 5. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein.
    Ito Y, Nakamura S, Onoda Y, Sugawara Y, Takaiti O.
    Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515
    [Abstract] [Full Text] [Related]

  • 6. The inactivation by carbenoxolone of individual human pepsinogens and pepsins.
    Roberts NB, Taylor WH.
    Clin Sci Mol Med; 1973 Aug; 45(2):213-24. PubMed ID: 4206390
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antacids and antipeptic agents].
    Belousov AS, Mamedova LD, Zel'din VE, Rakitskaia LG, Loranskaia ID.
    Klin Med (Mosk); 1989 Sep; 67(9):123-9. PubMed ID: 2511377
    [No Abstract] [Full Text] [Related]

  • 11. [Changed composition of gastric mucosa following carbenoxolone treatment].
    Maiwald L, Weicker U.
    Z Gastroenterol; 1972 Sep; 10(1):17-21. PubMed ID: 4671734
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE, Seethaler K, Lippmann W.
    Arzneimittelforschung; 1979 Sep; 29(5):793-8. PubMed ID: 387045
    [Abstract] [Full Text] [Related]

  • 14. The action of carbenoxolone on enzymes, with special reference to the pepsins and their secretion.
    Roberts NB, Walker V, Etherington DJ, Baron JH, McConnell RB, Taylor WH.
    Acta Gastroenterol Belg; 1983 Sep; 46(9-10):448-58. PubMed ID: 6424375
    [No Abstract] [Full Text] [Related]

  • 15. Effects of carbenoxolone Na on acute and chronic gastric ulcer models in experimental animals.
    Okabe S, Takata Y, Takeuchi K, Naganuma T, Takagi K.
    Am J Dig Dis; 1976 Aug; 21(8):618-25. PubMed ID: 986116
    [Abstract] [Full Text] [Related]

  • 16. Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone.
    Doll R, Langman MJ, Shawdon HH.
    Gut; 1968 Feb; 9(1):42-5. PubMed ID: 5640925
    [No Abstract] [Full Text] [Related]

  • 17. New therapeutic agents for peptic ulcer.
    Augur NA.
    J Maine Med Assoc; 1971 Oct; 62(10):245-6 passim. PubMed ID: 4937792
    [No Abstract] [Full Text] [Related]

  • 18. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP, Roberts NB.
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [Abstract] [Full Text] [Related]

  • 19. [New antipeptic agents for the treatment of peptic ulcer].
    Fisher AA, Poliak RI.
    Acta Anaesthesiol; 1968 Apr; 19(3):8-14. PubMed ID: 4910014
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.